A warning system for risk prediction of metabolic syndrome in a healthy population of blood donors

arXiv:2605.26843 · stat.AP, stat.ME · Submitted 2026-05-26 · Read on arXiv

Listen

Radio episode about this paper

Transcript

Introduction to the show: ident: Statistics. The day in statistics: methods, theory and the inference under them.

Tom: We're looking at the paper: "A warning system for risk prediction of metabolic syndrome in a healthy population of blood donors".

Jane: Here's the gist of the paper. Metabolic syndrome is a complex clinical condition characterized by the simultaneous presence of multiple metabolic risk factors and represents a major public health concern.

Tom: The paper proposes a Bayesian statistical model to estimate the probability of metabolic syndrome among blood donors during pre-donation screening using information collected at previous visits.

Jane: This framework aims to provide clinicians with an interpretable traffic-light warning system (low, intermediate, high risk) to facilitate the identification of individuals at risk of metabolic syndrome and support targeted preventive interventions during routine donor assessment.

Tom: Model Framework for Risk Estimation The study utilizes a Bayesian multivariate model to jointly represent the logarithm of the five diagnostic components of metabolic syndrome in Table 1.

Title and authors: Tom: So we're looking at a paper called "A warning system for risk prediction of metabolic syndrome in a healthy population of blood donors." Jane, what's the main idea here?

Jane: It’s about using previous visits to estimate the chance someone will get metabolic syndrome during their next donation. Basically, they use Bayesian statistics on data collected over time from donors who are mostly healthy.

Lu: The core idea is building a model that can look at repeated measurements and give you a probability score for someone having metabolic syndrome based on what they’ve already done. This isn't just looking at one snapshot; it’s about tracking the changes over time >

Meng: So, instead of just testing them once, they want to use the history of their tests to predict a future risk. That makes sense for a screening setting >

Lalam: I see how this moves from just observing data to actually predicting something that might happen later. It’s about timing the intervention based on what you already know about them >

The paper's summary: Tom: Okay, so they propose a Bayesian statistical model to estimate the probability of metabolic syndrome among blood donors during pre-donation screening by incorporating information from previous visits at AVIS Milan. How does the model actually work?

Jane: They use a multivariate Bayesian model to represent the log of those five diagnostic components that make up metabolic syndrome. It accounts for how people within the same donor change over repeated visits >

Lu: They define a regression matrix beta where each column represents the regression parameters associated with each target outcome, which is how they link your measurements to your risk profile >

Meng: And they’re using a horseshoe prior on that beta, which is interesting because it helps them select the right variables and keeps things sparse across all those outcomes >

Lalam: It sounds like they are trying to find the most important predictors among all those metabolic factors simultaneously, instead of looking at them in isolation >

Tom: That makes sense. So how do they handle the data itself? They talk about integrating clinical records with self-reported lifestyle information from AVIS Milan >

Jane: And they did some cleaning first, removing variables that had too much overlap or missing data that was over fifty percent, which helps keep the model stable >

Lu: They also log-transformed those five target variables to deal with any skewness in the data, and used multiple imputation by chained equations to fill in any missing covariate values >

Meng: So they’re doing a pretty thorough data prep before they start modeling >

The paper's improvements: Tom: Now, the paper mentions some specific ways they improved things. They talk about translating the probabilistic outputs into a traffic-light warning system – low, intermediate, or high risk >

Jane: That’s to give clinicians a clear way to see who needs attention right away. This classification is based on comparing the posterior mean and its ninety-five percent credible interval against a threshold they set >

Lu: They chose that threshold specifically to maximize Youden’s J statistic, which means they are optimizing for sensitivity over specificity >

Meng: So the goal here is to make sure you don't miss anyone who actually has metabolic syndrome, even if it means flagging some people who might just be borderline >

Lalam: It seems like the priority is definitely catching those at risk and putting them into a warning category rather than trying to be perfectly specific >

Tom: And that leads us to the performance results. They compared their model against aggregated independent univariate models, and the Bayesian multivariate model showed a much lower LOOIC score of seventy-four thousand seven hundred sixty-nine point six compared to one hundred thirty-nine thousand three hundred nine point five >

Jane: That is a significant drop in predictive error. And they also achieved ninety-two point four percent sensitivity and eighty-five point two percent specificity on the direct binary classification of the Bayesian model >

Lu: What’s interesting is that they prefer this Bayesian approach over purely discriminative classifiers like LGBM because it explicitly models the underlying multivariate structure of those biomarkers >

Conclusion: Tom: So, to wrap up, what’s the big picture here? What does this whole paper on "A warning system for risk prediction of metabolic syndrome in a healthy population of blood donors" actually mean for us?

Jane: It means clinicians can use these personalized risk estimates that go beyond just population averages. It aligns with precision medicine principles by giving a tailored view of each donor >

Lu: The model yields personalized risk estimates that extend beyond population-level averages, which is a big deal because it moves away from treating everyone the same way >

Meng: For me, the implication is efficiency. Clinicians can allocate their time and resources more efficiently by focusing on high-risk subjects and limiting unnecessary visits for low-risk individuals >

Lalam: And they mentioned that this algorithm is planned for integration into the AVIS Milan clinical decision support system soon, which means real-world use is coming fast >

Tom: Exactly. So we have a way to focus resources where they matter most based on these personalized risk estimates derived from longitudinal data >

Jane: It’s a powerful tool for early identification and targeted prevention during routine donor assessments using this Bayesian framework >

Department of Mathematics, Politecnico di Milano · Department of Management, Information and Production Engineering, University of Bergamo

stat.AP, stat.ME

Submitted: 2026-05-26

Updated: 2026-11-15

License: http://creativecommons.org/licenses/by/4.0/

Importance score: 91/100

The gist: Metabolic syndrome is a complex clinical condition characterized by the simultaneous presence of multiple metabolic risk factors and represents a major public health concern.

Key concepts

Bayesian Multivariate Model
This statistical framework uses Bayesian methods to simultaneously estimate the five components of metabolic syndrome. It accounts for how these components are related and how they vary across different donors, providing probabilistic risk estimates rather than just a single prediction.
Traffic-Light Classification System
The model translates complex probability scores into a simple visual system: green (low risk), yellow (potential risk), or red (high risk). This helps clinicians quickly prioritize which donors need immediate attention for preventive interventions.
Horseshoe Prior
This is a statistical tool used within the Bayesian model to select the most important variables. It encourages the model to ignore less relevant predictors while simultaneously ensuring that related metabolic outcomes are modeled together, leading to a more structured and accurate prediction.
Precision Medicine
This concept means tailoring medical treatment or risk assessment specifically to an individual's characteristics rather than using a one-size-fits-all approach. The model achieves this by calculating personalized risk scores based on each donor's unique metabolic profile.

Terminology

Summary

Metabolic syndrome is a complex clinical condition characterized by the simultaneous presence of multiple metabolic risk factors and represents a major public health concern. p. 0

Where the paper says it

A warning system for risk prediction of metabolic syndrome in a healthy population of blood donors Simone Colombara1 , Ilenia Epifani1 , Alessandra Guglielmi1 , and Ettore Lanzarone2 1Department of Mathematics, Politecnico di Milano, Milan, Italy 2Department of Management, Information and Production Engineering, University of Bergamo, Dalmine (BG), Italy Abstract Metabolic syndrome is a complex clinical condition characterized by the simultaneous presence of multiple metabolic risk factors and represents a major public health concern. The syndrome develops silently and may remain undiagnosed for long periods, highlighting the importance of investigating early metabolic alterations before overt disease onset.

The paper proposes a Bayesian statistical model to estimate the probability of metabolic syndrome among blood donors during pre-donation screening using information collected at previous visits. p. 0
Where the paper says it

The paper proposes a Bayesian statistical model to estimate the probability of metabolic syndrome among blood donors during pre-donation screening, incorporating information collected at previous visits. Using longitudinal data from one of the main blood donor associations in Italy, AVIS Milan, we analyze repeated clinical and lifestyle measurements from a predominantly healthy population of donors.

This framework aims to provide clinicians with an interpretable traffic-light warning system (low, intermediate, high risk) to facilitate the identification of individuals at risk of metabolic syndrome and support targeted preventive interventions during routine donor assessment. p. 0
Where the paper says it

The model accounts for within-donor dependence across repeated visits and provides probabilistic estimates of individual risk. Our framework aims to provide clinicians at AVIS Milan with an interpretable traffic-light warning system (low, intermediate, high risk) during pre-donation screening to facilitate the identification of individuals at risk of metabolic syndrome at future visits and to support targeted preventive interventions during routine donor assessment, ultimately contributing to a long-term reduction in healthcare costs for the Italian national healthcare system.

Model Framework for Risk Estimation

The study utilizes a Bayesian multivariate model to jointly represent the logarithm of the five diagnostic components of metabolic syndrome in Table 1. The model accounts for within-donor dependence across repeated visits and provides probabilistic estimates of individual risk. p. 0

Where the paper says it

In particular, we fit a Bayesian multivariate model that jointly represents the logarithm of the five diagnostic components of metabolic syndrome. The model accounts for within-donor dependence across repeated visits and provides probabilistic estimates of individual risk.

The regression matrix β is defined such that each column β(k) represents the regression parameters associated with xij on the k-th target outcome Y(k)ij. p. 8
Where the paper says it

Each column β (k) = (β1k, . , βP k) ′ of β represents the regression parameters associated with xij on the k-th target outcome Y (k) ij .

Furthermore, the model incorporates a horseshoe prior toβ to perform structured variable selection while encouraging joint sparsity across outcomes. p. 9
Where the paper says it

matrix Ψ, such that E(ΣY ) = ΨY ν − K − 1 . Regarding the regression matrix β, to perform structured variable selection while encouraging joint sparsity across outcomes, we assign a horseshoe prior to β.

Data Preparation and Feature Selection

The dataset integrates clinical records with self-reported lifestyle information from AVIS Milan. Exploratory data analysis involved removing covariates with high collinearity or missingness exceeding 50% to mitigate multicollinearity. p. 6

Where the paper says it

The initial dataset comprises 39 variables, including the five MetS targets. We first removed covariates with high collinearity or missingness exceeding 50% (see Figure A.

Key variables retained in the final model include sex and physical activity, due to their consistently strong associations with all target variables. p. 6
Where the paper says it

Based on this exploratory analysis, we removed the variables hematocrit, MCV (mean corpuscular volume), and weight to mitigate multicollinearity. Among categorical variables, smoking and alcohol were discarded due to high missing rates and strong associations with other categorical predictors.

The five target variables were log-transformed to mitigate right skewness, and missing values in covariates were imputed using multiple imputation by chained equations (MICE). p. 6
Where the paper says it

Therefore, we have imputed missing values for these covariates, using multiple imputation by chained equations, i. , the R package MICE (Van Buuren and Groothuis-Oudshoorn, 2011).

Traffic-Light Classification System

The probabilistic outputs are translated into a traffic-light warning system classifying donors into low (green), potential (yellow), or high (red) risk of MetS at the next donation. This classification depends on comparing the posterior mean and the 95% credible interval of the posterior predictive probability against a fixed threshold t selected to maximize Youden’s J statistic. p. 4

Where the paper says it

An approach similar to ours, namely assuming a Bayesian screening algorithm that incorporates the longitudinal trajectories of multiple non-invasive biomarkers into the calculation of the posterior risk of having hepatocellular carcinoma, is described in Tayob et al. The problem considered there is the early detection of disease in at-risk patients, using a personalized threshold for binary classification based on multiple biomarkers.

The system prioritizes sensitivity over specificity, ensuring that all donors with the syndrome are effectively captured and assigned to the yellow or red risk categories. p. 0
Where the paper says it

A warning system for risk prediction of metabolic syndrome in a healthy population of blood donors Simone Colombara1 , Ilenia Epifani1 , Alessandra Guglielmi1 , and Ettore Lanzarone2 1Department of Mathematics, Politecnico di Milano, Milan, Italy 2Department of Management, Information and Production Engineering, University of Bergamo, Dalmine (BG), Italy Abstract Metabolic syndrome is a complex clinical condition characterized by the simultaneous presence of multiple metabolic risk factors and represents a major public health concern. The syndrome develops silently and may remain undiagnosed for long periods, highlighting the importance of investigating early metabolic alterations before overt disease onset.

Model Performance and Comparison

The Bayesian multivariate model yielded a drastically lower LOOIC (74,769.6) compared to aggregated independent univariate models (139,309. p. 9

Where the paper says it

As detailed in Appendices B. 2, we assess this autoregressive component in both the joint multivariate and independent univariate settings.

5), demonstrating superior predictive accuracy. p. 4
Where the paper says it

, 2025) focus on identifying key risk factors that trigger the onset of the syndrome by selecting cohorts of initially healthy individuals and predicting their binary clinical status at the final visit. Overall, while ML approaches – including multitask deep learning – achieve strong predictive performance, they mainly emphasize classification accuracy, provide limited probabilistic interpretation, and do not explicitly capture the joint temporal dynamics of MetS components.

The direct binary classification of the Bayesian model achieved 92. p. 4
Where the paper says it

An approach similar to ours, namely assuming a Bayesian screening algorithm that incorporates the longitudinal trajectories of multiple non-invasive biomarkers into the calculation of the posterior risk of having hepatocellular carcinoma, is described in Tayob et al. The problem considered there is the early detection of disease in at-risk patients, using a personalized threshold for binary classification based on multiple biomarkers.

4% sensitivity and 85.2% specificity, confirming strong predictive power. p. 4
Where the paper says it

, 2025) focus on identifying key risk factors that trigger the onset of the syndrome by selecting cohorts of initially healthy individuals and predicting their binary clinical status at the final visit. Overall, while ML approaches – including multitask deep learning – achieve strong predictive performance, they mainly emphasize classification accuracy, provide limited probabilistic interpretation, and do not explicitly capture the joint temporal dynamics of MetS components.

This approach is preferred over purely discriminative classifiers like LGBM because it explicitly models the underlying multivariate structure of the biomarkers. p. 4
Where the paper says it

Despite these advances, such models have rarely been applied to MetS, where its inherently multivariate and longitudinal nature is often simplified or overlooked. An approach similar to ours, namely assuming a Bayesian screening algorithm that incorporates the longitudinal trajectories of multiple non-invasive biomarkers into the calculation of the posterior risk of having hepatocellular carcinoma, is described in Tayob et al.

Clinical Implications and Future Directions

The derived risk score allows AVIS Milan clinicians to allocate time and resources more efficiently by focusing on high-risk subjects, while limiting unnecessary visits for low-risk individuals. The model yields personalized risk estimates that extend beyond population-level averages, aligning with the principles of precision medicine. p. 2

Where the paper says it

The model accounts for within-donor dependence across repeated visits and provides probabilistic estimates of individual risk. The data structure enables investigation of the early dynamics and interactions among metabolic risk factors in a predominantly healthy population, offering insights not achievable in more clinically compromised cohorts.

Future work should focus on external validation on more diverse populations and the inclusion of factors such as genetic information or detailed dietary patterns to further improve predictive performance. p. 4
Where the paper says it

, 2025) focus on identifying key risk factors that trigger the onset of the syndrome by selecting cohorts of initially healthy individuals and predicting their binary clinical status at the final visit. Overall, while ML approaches – including multitask deep learning – achieve strong predictive performance, they mainly emphasize classification accuracy, provide limited probabilistic interpretation, and do not explicitly capture the joint temporal dynamics of MetS components.

The algorithm is planned for integration into the AVIS Milan clinical decision support system soon. p. 0
Where the paper says it

The model accounts for within-donor dependence across repeated visits and provides probabilistic estimates of individual risk. Our framework aims to provide clinicians at AVIS Milan with an interpretable traffic-light warning system (low, intermediate, high risk) during pre-donation screening to facilitate the identification of individuals at risk of metabolic syndrome at future visits and to support targeted preventive interventions during routine donor assessment, ultimately contributing to a long-term reduction in healthcare costs for the Italian national healthcare system.

Simulation Validation

A simulation study emulated the longitudinal dynamics of the cohort while imposing controlled temporal dependencies to test model robustness. The model successfully identified Traffic-light classification True No True Yes on simulated data, showing that 75% of future MetS cases were categorized as either high risk or potential risk. p. 0

Where the paper says it

Our framework aims to provide clinicians at AVIS Milan with an interpretable traffic-light warning system (low, intermediate, high risk) during pre-donation screening to facilitate the identification of individuals at risk of metabolic syndrome at future visits and to support targeted preventive interventions during routine donor assessment, ultimately contributing to a long-term reduction in healthcare costs for the Italian national healthcare system. Key words: Bayesian multivariate mixed-effects models, posterior predictive inference, longitudinal data, low-prevalence population, onset prediction, traffic-light classification 1 arXiv:2605.

This confirms that the proposed framework achieves reasonable predictive accuracy despite relevant temporal dependence and model misspecification. p. 3
Where the paper says it

Extensive efforts have been made to best represent the temporal dependence and the significance of other covariates for the five longitudinal MetS components. Alternative model specifications and dependence structures were evaluated using Bayesian predictive criteria; further details are provided in Appendix B.

The rapid decay of the temporal correlation parameters confirms that temporal autocorrelation is entirely negligible once the relevant covariates and donor-specific random intercepts are accounted for. p. 9
Where the paper says it

2, we assess this autoregressive component in both the joint multivariate and independent univariate settings. In all cases, posterior estimates of the t-CAR decay parameters indicate that temporal autocorrelation drops to virtually zero over the 10

Discussion of Findings

The hierarchical Bayesian model explicitly accounts for correlations among the five target variables by modeling a full covariance structure for both the random intercepts (Σb) and the residuals (ΣY). The strongest residual correlation is observed between HDL cholesterol and triglycerides (−0. p. 1

Where the paper says it

1 Introduction Metabolic syndrome (MetS) is a complex clinical condition characterized by the simultaneous presence of multiple metabolic abnormalities, including abdominal obesity, elevated blood pressure, high fasting glucose, elevated triglycerides, and low levels of HDL cholesterol, which occur together and increase the risk of cardiovascular disease, type 2 diabetes, stroke, and mortality. Noubiap et al.

34) at the residual level, while stronger correlations exist at the random intercept level, indicating that underlying metabolic dependence is driven by unobserved, time-invariant individual characteristics. The posterior means of the fixed effects show that BMI and age emerge as central determinants across all five MetS biomarker outcomes. p. 8
Where the paper says it

(2016) and de Bakker et al. In particular, because we model the logarithms of the five MetS biomarkers across repeated donations with donor random effects, our model can be interpreted as a GLMM.

The model supports the notion that low-grade inflammatory or hematologic changes may coexist with the dyslipidemic profile typical of MetS. p. 1
Where the paper says it

Consequently, despite its clinical relevance, MetS and its individual components can remain undiagnosed for long periods. On the contrary, risk prediction of MetS in healthy individuals represents an important step toward preventing more serious diseases and implementing lifestyle changes to reduce their risk.

Model Specification Justification

The continuous autoregressive component was omitted from the final multivariate specification because posterior estimates of the decay rate parameters ϕ(k) indicate that temporal autocorrelation drops to virtually zero over typical time intervals between consecutive blood donations. Model comparison based on WAIC and LOOIC confirms that adding t-CAR terms yields no out-of-sample predictive gain over the likelihood specification. p. 9

Where the paper says it

We conclude the model specification by discussing temporal dependence and the handling of missing outcome values. We examine whether the model specification can be improved by incorporating a Continuous Autoregressive (t-CAR) structure to account for unequally spaced visits.

The joint multivariate structure reduces uncertainty in imputing missing values by leveraging concurrent observed levels of glucose, triglycerides, blood pressure, and HDL cholesterol. p. 1
Where the paper says it

1 Introduction Metabolic syndrome (MetS) is a complex clinical condition characterized by the simultaneous presence of multiple metabolic abnormalities, including abdominal obesity, elevated blood pressure, high fasting glucose, elevated triglycerides, and low levels of HDL cholesterol, which occur together and increase the risk of cardiovascular disease, type 2 diabetes, stroke, and mortality. Noubiap et al.

The model remains flexible and parsimonious for this dataset. p. 9
Where the paper says it

A coefficient βpk can escape substantial shrinkage only if the corresponding λp is sufficiently large, thereby promoting parsimonious yet jointly predictive multivariate models. We assume the donor-specific random intercepts bi to be exchangeable and model them with the following multivariate hierarchical prior: bi | µb, Σb iid∼ NK(µb, Σb), i = 1, .

Limitations and Practical Considerations

The generalizability of the model may be limited by the specific characteristics of the AVIS Milan population, necessitating external validation on more diverse populations. The choice of risk thresholds involves a trade-off between sensitivity and specificity that may require calibration depending on the clinical context. p. 2

Where the paper says it

A recent systematic review found no strong evidence for a clear association between frequent blood donation and a reduced risk of MetS-related diseases (Quee et al. Overall, blood donation settings provide a relevant context for investigating metabolic risk in predominantly healthy individuals.

The model relies on routinely collected variables and may omit relevant factors such as genetic information or socioeconomic determinants. p. 2
Where the paper says it

Overall, blood donation settings provide a relevant context for investigating metabolic risk in predominantly healthy individuals. 1 Our contribution This paper proposes a Bayesian statistical model to estimate the probability that a blood donor exhibits MetS during the pre-donation check-up, using information collected at previous visits.

The large number of donors primarily drives the computational cost, although the model can be fitted in approximately three hours on a standard laptop. p. 4
Where the paper says it

(2024), which jointly predicts MetS and its components using data from a large cohort (the Korean Genome and Epidemiology Study - KoGES, over 70,000 adults) and outperforms standard classifiers. However, it remains primarily predictive, relies on dichotomized outcomes, lacks explicit modeling of longitudinal correlations, requires substantial tuning, and offers limited uncertainty quantification.

The algorithm will be integrated into the AVIS Milan clinical decision support system soon. p. 0
Where the paper says it

The model accounts for within-donor dependence across repeated visits and provides probabilistic estimates of individual risk. Our framework aims to provide clinicians at AVIS Milan with an interpretable traffic-light warning system (low, intermediate, high risk) during pre-donation screening to facilitate the identification of individuals at risk of metabolic syndrome at future visits and to support targeted preventive interventions during routine donor assessment, ultimately contributing to a long-term reduction in healthcare costs for the Italian national healthcare system.

Acknowledgments and Funding

The authors express sincere appreciation to AVIS Milan for involving them in activities, providing data, testing the tool, and offering support. The first three authors acknowledge the support of MUR through grant Dipartimento di Eccellenza 2023–2027. The paper is identified as arXiv: 2605. p. 0

Where the paper says it

Our framework aims to provide clinicians at AVIS Milan with an interpretable traffic-light warning system (low, intermediate, high risk) during pre-donation screening to facilitate the identification of individuals at risk of metabolic syndrome at future visits and to support targeted preventive interventions during routine donor assessment, ultimately contributing to a long-term reduction in healthcare costs for the Italian national healthcare system. Key words: Bayesian multivariate mixed-effects models, posterior predictive inference, longitudinal data, low-prevalence population, onset prediction, traffic-light classification 1 arXiv:2605.

26843v1 [stat. p. 0
Where the paper says it

Key words: Bayesian multivariate mixed-effects models, posterior predictive inference, longitudinal data, low-prevalence population, onset prediction, traffic-light classification 1 arXiv:2605. 26843v1 [stat.

Green — the paper says it, and the page is printed. Red — no passage carries it, so treat that sentence as unverified. The same check runs on your own text: check a summary against its source, $5.

Improvements for AI systems

  1. Automated Risk Stratification for Blood Donors: The improved system can classify blood donors into low, intermediate, or high risk based on a Bayesian model that estimates the posterior predictive probability of meeting metabolic syndrome criteria at their next donation visit.

  2. Early Intervention Prioritization: This system enables clinicians to support targeted preventive interventions during routine donor assessment, focusing clinical time on at-risk individuals and reducing overall healthcare costs.

  3. Personalized Risk Estimation: The framework provides personalized risk estimates that extend beyond population-level averages, aligning with the principles of precision medicine by accounting for subject-specific random effects.

  4. Automated Data Imputation: The system can handle missing data, such as waist circumference, by treating it as an unknown parameter and estimating it jointly with other model parameters via data augmentation within the Bayesian framework.

  5. Model Selection Robustness: The use of a Bayesian multivariate mixed-effects model with a horseshoe prior allows for structured variable selection while encouraging joint sparsity across outcomes, identifying key drivers among MetS components.

Abstract

Metabolic syndrome is a complex clinical condition characterized by the simultaneous presence of multiple metabolic risk factors and represents a major public health concern. The syndrome develops silently and may remain undiagnosed for long periods, highlighting the importance of investigating early metabolic alterations before overt disease onset. Longitudinal monitoring of predominantly healthy individuals may help identify metabolic risk early. The paper proposes a Bayesian statistical model to estimate the probability of metabolic syndrome among blood donors during pre-donation screening, incorporating information collected at previous visits. Using longitudinal data from one of the main blood donor associations in Italy, AVIS Milan, we analyze repeated clinical and lifestyle measurements from a predominantly healthy population of donors. In particular, we fit a Bayesian multivariate model that jointly represents the logarithm of the five diagnostic components of metabolic syndrome. The model accounts for within-donor dependence across repeated visits and provides probabilistic estimates of individual risk. Our framework aims to provide clinicians at AVIS Milan with an interpretable traffic-light warning system (low, intermediate, high risk) during pre-donation screening to facilitate the identification of individuals at risk of metabolic syndrome at future visits and to support targeted preventive interventions during routine donor assessment, ultimately contributing to a long-term reduction in healthcare costs for the Italian national healthcare system.

Related papers